These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause. Gérard C; Arnal JF; Jost M; Douxfils J; Lenfant F; Fontaine C; Houtman R; Archer DF; Reid RL; Lobo RA; Gaspard U; Coelingh Bennink HJT; Creinin MD; Foidart JM Expert Rev Clin Pharmacol; 2022 Feb; 15(2):121-137. PubMed ID: 35306927 [TBL] [Abstract][Full Text] [Related]
4. Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms. Gérard C; Mestdagt M; Tskitishvili E; Communal L; Gompel A; Silva E; Arnal JF; Lenfant F; Noel A; Foidart JM; Péqueux C Oncotarget; 2015 Jul; 6(19):17621-36. PubMed ID: 26056044 [TBL] [Abstract][Full Text] [Related]
5. Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive. Nelson AL Expert Opin Pharmacother; 2023; 24(16):1757-1764. PubMed ID: 37691580 [TBL] [Abstract][Full Text] [Related]
6. Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action. Gérard C; Foidart JM Drugs R D; 2023 Jun; 23(2):77-92. PubMed ID: 37133685 [TBL] [Abstract][Full Text] [Related]
7. Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer. Gallez A; Blacher S; Maquoi E; Konradowski E; Joiret M; Primac I; Gérard C; Taziaux M; Houtman R; Geris L; Lenfant F; Marangoni E; Sounni NE; Foidart JM; Noël A; Péqueux C Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065180 [TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications. Battipaglia C; Feliciello L; Genazzani AD; Facchinetti F; Grandi G Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):871-879. PubMed ID: 37942662 [TBL] [Abstract][Full Text] [Related]
9. Insights on estetrol, the native estrogen: from contraception to hormone replacement therapy. Battipaglia C; Genazzani AD; Nappi RE; La Marca A Minerva Obstet Gynecol; 2024 Sep; ():. PubMed ID: 39283289 [TBL] [Abstract][Full Text] [Related]
10. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. Hilakivi-Clarke L; de Assis S; Warri A J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):25-42. PubMed ID: 23392570 [TBL] [Abstract][Full Text] [Related]
11. Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women. Coelingh Bennink HJ; Verhoeven C; Zimmerman Y; Visser M; Foidart JM; Gemzell-Danielsson K Maturitas; 2016 Sep; 91():93-100. PubMed ID: 27451327 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer. Schmidt M; Lenhard H; Hoenig A; Zimmerman Y; Krijgh J; Jansen M; Coelingh Bennink HJT J Cancer Res Clin Oncol; 2021 Jun; 147(6):1833-1842. PubMed ID: 33242131 [TBL] [Abstract][Full Text] [Related]
14. Estetrol and the possibilities of its clinical use. Křepelka Petr Ceska Gynekol; 2021; 86(3):217-221. PubMed ID: 34167315 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694 [TBL] [Abstract][Full Text] [Related]
16. Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis. Valéra MC; Noirrit-Esclassan E; Dupuis M; Fontaine C; Lenfant F; Briaux A; Cabou C; Garcia C; Lairez O; Foidart JM; Payrastre B; Arnal JF Mol Cell Endocrinol; 2018 Dec; 477():132-139. PubMed ID: 29928930 [TBL] [Abstract][Full Text] [Related]
18. Hormones and breast cancer. ESHRE Capri Workshop Group Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054 [TBL] [Abstract][Full Text] [Related]
19. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
20. Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation. Benoit T; Valera MC; Fontaine C; Buscato M; Lenfant F; Raymond-Letron I; Tremollieres F; Soulie M; Foidart JM; Game X; Arnal JF Am J Pathol; 2017 Nov; 187(11):2499-2507. PubMed ID: 28827141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]